Literature DB >> 19189196

Serological survey of avian H5N2-subtype influenza virus infections in human populations.

Yoshinao Yamazaki1, Mikio Doy, Nobuhiko Okabe, Yoshinori Yasui, Kazutoshi Nakashima, Takashi Fujieda, Shin-ichi Yamato, Yuichi Kawata, Tsuyoshi Ogata.   

Abstract

To investigate the distribution of antibodies against H5N2 influenza virus in humans living in Ibaraki prefecture, Japan, 266 single serum samples were collected to perform serological tests. Results were compared to investigate the relationship between positive results and several factors. The number of positive serum neutralization antibody titers (> or = 40) against avian influenza virus A/H5N2 was significantly greater (P < 0.05) among poultry workers, in comparison to a Japanese healthy population. The geometric mean titers of serum neutralization antibody against A/H5N2 were significantly higher (P < 0.05) among Ibaraki inhabitants and poultry workers (P < 0.0001) when compared to a Japanese healthy population. Seropositivity against A/H5N2 virus was significantly (P < 0.05) associated with age (> or = 50 years old) in poultry workers. These results suggest that seropositivity against H5N2 virus in Ibaraki specimens is significantly higher than those of a Japanese healthy population and that the surveillance of avian influenza viruses is very important to evaluate the invasion or emergence of new pandemic influenza viruses from species other than humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189196     DOI: 10.1007/s00705-009-0319-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  A point mutation in the polymerase protein PB2 allows a reassortant H9N2 influenza isolate of wild-bird origin to replicate in human cells.

Authors:  Islam T M Hussein; Eric J Ma; Nichola J Hill; Brandt W Meixell; Mark Lindberg; Randy A Albrecht; Justin Bahl; Jonathan A Runstadler
Journal:  Infect Genet Evol       Date:  2016-04-14       Impact factor: 3.342

2.  Human H5N2 bird flu infection: fact or fallacy?

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

3.  APPENDIX 1: Evidence Review on Occupational Exposure of Swine and Poultry Workers: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2013-10-10

4.  A national study of individuals who handle migratory birds for evidence of avian and swine-origin influenza virus infections.

Authors:  Shira C Shafir; Trevon Fuller; Thomas B Smith; Anne W Rimoin
Journal:  J Clin Virol       Date:  2012-05-24       Impact factor: 3.168

5.  Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses.

Authors:  Richard Sutejo; Dawn S Yeo; Myint Zu Myaing; Chen Hui; Jiajia Xia; Debbie Ko; Peter C F Cheung; Boon-Huan Tan; Richard J Sugrue
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

6.  Influenza A(H5N2) virus antibodies in humans after contact with infected poultry, Taiwan, 2012.

Authors:  Ho-Sheng Wu; Ji-Rong Yang; Ming-Tsan Liu; Chin-Hui Yang; Ming-Chu Cheng; Feng-Yee Chang
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

Review 7.  Weighing serological evidence of human exposure to animal influenza viruses - a literature review.

Authors:  Reina Saapke Sikkema; Gudrun Stephanie Freidl; Erwin de Bruin; Marion Koopmans
Journal:  Euro Surveill       Date:  2016-11-03

8.  Characterization of Novel Reassortant Influenza A (H5N2) Viruses Isolated from Poultry in Eastern China, 2015.

Authors:  Haibo Wu; Rufeng Lu; Xiuming Peng; Xiaorong Peng; Linfang Cheng; Fumin Liu; Nanping Wu
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

9.  Environmental correlates of H5N2 low pathogenicity avian influenza outbreak heterogeneity in domestic poultry in Italy.

Authors:  Lapo Mughini-Gras; Lebana Bonfanti; Paolo Mulatti; Isabella Monne; Vittorio Guberti; Paolo Cordioli; Stefano Marangon
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.